PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.792
+0.012 (1.51%)
Feb 21, 2025, 4:00 PM EST - Market closed
PAVmed Employees
PAVmed had 107 employees as of December 31, 2023. The number of employees decreased by 17 or -13.71% compared to the previous year.
Employees
107
Change (1Y)
-17
Growth (1Y)
-13.71%
Revenue / Employee
$37,701
Profits / Employee
$137,523
Market Cap
8.76M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
PAVM News
- 2 days ago - Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health - PRNewsWire
- 4 days ago - PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement - PRNewsWire
- 15 days ago - Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - PRNewsWire
- 5 weeks ago - Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume - PRNewsWire
- 2 months ago - Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - PRNewsWire
- 2 months ago - Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters - PRNewsWire
- 2 months ago - Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication - PRNewsWire
- 2 months ago - Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones - PRNewsWire